Cargando…

Toll-like receptor 9 interaction with CpG ODN – An in silico analysis approach

BACKGROUND: Toll-like receptor 9 (TLR9) recognises unmethylated CpG DNA and activates a signalling cascade, leading to the production of inflammatory cytokines such as TNF-α, IL-1, IL-6 and IL-12 via the adaptor protein MyD88. However, the specific sequence and structural requirements of the CpG DNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wei, Li, Yan, Pan, Xichun, Gao, Yuan, Li, Beiping, Qiu, Zhengliang, Liang, Long, Zhou, Hong, Yue, Junjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602074/ https://www.ncbi.nlm.nih.gov/pubmed/23497207 http://dx.doi.org/10.1186/1742-4682-10-18

Ejemplares similares

Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model
por: Golali, Ensieh, et al.
Publicado: (2012)

Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice
por: Krogmann, Alexander O., et al.
Publicado: (2016)

The effect of CpG-ODN on antigen presenting cells of the foal
por: Flaminio, M Julia BF, et al.
Publicado: (2007)

Effect of CpG ODN on monocytic myeloid derived suppressor cells
por: Shirota, Hidekazu, et al.
Publicado: (2012)

TRAIL is involved in CpG ODN-mediated anti-apoptotic signals
por: LIM, EUN-JUNG, et al.
Publicado: (2011)

Identification of Differentially Expressed lncRNAs in a CpG ODN-Activated Macrophage
por: Zheng, Ying, et al.
Publicado: (2020)

Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial
por: Ursu, Renata, et al.
Publicado: (2015)

TLR9-mediated ARF6 activation is involved in advancing CpG ODN cellular uptake
por: Wu, Jing-Yiing, et al.
Publicado: (2012)

Limited Effect of CpG ODN in Preventing Type 1 Diabetes in NOD Mice
por: Lee, Byong Jun, et al.
Publicado: (2005)

Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
por: Gungor, Bilgi, et al.
Publicado: (2014)

Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant
por: Ito, Sayami, et al.
Publicado: (2020)

Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21
por: Lai, Chao-Yang, et al.
Publicado: (2019)

Activation of CpG-ODN-Induced TLR9 Signaling Inhibited by Interleukin-37 in U937 Human Macrophages
por: Kim, Seong-Kyu, et al.
Publicado: (2021)

The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice
por: Hejazi, H, et al.
Publicado: (2010)

Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation
por: De Cecco, Loris, et al.
Publicado: (2013)

CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi Infection
por: Kumar, Parveen, et al.
Publicado: (2015)

Pleiotropic action of CpG-ODN on endothelium and macrophages attenuates angiogenesis through distinct pathways
por: Wu, Jiahui, et al.
Publicado: (2016)

Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line
por: Wang, Shu, et al.
Publicado: (2017)

Treatment with phosphodiester CpG-ODN ameliorates atopic dermatitis by enhancing TGF-β signaling
por: Ham, Won-Kook, et al.
Publicado: (2021)

CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo
por: Knuefermann, Pascal, et al.
Publicado: (2007)

Single Molecule In Vivo Analysis of Toll-Like Receptor 9 and CpG DNA Interaction
por: Chen, Jiji, et al.
Publicado: (2011)

High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
por: Sommariva, Michele, et al.
Publicado: (2013)

Preparation and characterization of PLGA nanospheres loaded with inactivated influenza virus, CpG-ODN and Quillaja saponin
por: Mohajer, Maryam, et al.
Publicado: (2014)

In Ovo Administration of CpG ODN Induces Expression of Immune Response Genes in Neonatal Chicken Spleen
por: Sajewicz-Krukowska, Joanna, et al.
Publicado: (2017)

Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations
por: Kang, Hae-Ji, et al.
Publicado: (2020)

Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists
por: Meng, Wenjun, et al.
Publicado: (2011)

Equilibrium Binding Model for CpG DNA-Dependent Dimerization of Toll-like Receptor 9 Ectodomain
por: Reikine, Stephanie, et al.
Publicado: (2020)

The Toll-like receptor ligand, CpG oligodeoxynucleotides, regulate proliferation and osteogenic differentiation of osteoblast
por: Yu, Wenwen, et al.
Publicado: (2020)

Effects of Toll-like receptor 9 and CpG oligodeoxynucleotides 1826 on sodium taurocholate-induced acute pancreatitis rats
por: Sun, Liang, et al.
Publicado: (2018)

CpG-ODN and MPLA Prevent Mortality in a Murine Model of Post-Hemorrhage-Staphyloccocus aureus Pneumonia
por: Roquilly, Antoine, et al.
Publicado: (2010)

Plasmacytoid Dendritic Cell Response to CpG ODN Correlates with CXCL16 Expression and Is Inhibited by ox-LDL
por: Gursel, Mayda, et al.
Publicado: (2013)

CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10
por: Mirotti, Luciana, et al.
Publicado: (2017)

CpG-ODN Facilitates Effective Intratracheal Immunization and Recall of Memory against Neoantigen-Expressing Alveolar Cells
por: Riehn, Mathias, et al.
Publicado: (2017)

Immunogenicity evaluation of the HIV-1 Tat containing polyepitope DNA vaccine adjuvanted with CpG-ODNs in mice
por: Ollah Jazaeri, Ehsan, et al.
Publicado: (2021)

CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
por: Otsuka, Tomoyuki, et al.
Publicado: (2022)

The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo
por: Tian, Yaomei, et al.
Publicado: (2017)

The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide
por: Lai, Chunhui, et al.
Publicado: (2018)

Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2017)

Involvement of DNA-PKcs in the Type I IFN Response to CpG-ODNs in Conventional Dendritic Cells in TLR9-Dependent or -Independent Manners
por: Ma, Chi, et al.
Publicado: (2015)

The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8(+) T-cell responses in vitro
por: Papagno, Laura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r4g54sn33o65j7ack8qecb5m3c